
Studying Aquaponics: Program accepted in national initiative
COVENTRY — Several years ago, a student built a greenhouse dome from scratch for his senior project. Almost 10 years later, the project led to the creation of an aquaponics program, in which more and more students are taking an interest in.
The Aquaponics class was born after Alex Bohr's independent study project, which he did back in 2017 when he was a student at CHS. His project consisted of creating an aquaponics dome. The school then created a program and used the dome to grow plants using aquaponics technique.
This technique consists of using fish culture as a natural fertilizer to grow plants without using soil. This benefits both the fish culture and the plants growing industry, as plants use fishes' waist nutriment to grow and filter the water that returns to the fish.
The program was recently officially accepted into the American Heart Association's Teaching Gardens Network, which is a national initiative that supports school gardening and agricultural programs.
To join, the school had to fill out an online application, detailing the program and the number of students that are participating, as well as the garden's dimensions. Being part of the AHA is a good opportunity to get grants for the class or scholarships for students. They also have access to studying materials like lesson plans, lab activities and different curriculum.
Jacob Paciotti is the teacher who is now in charge of this class, which occurs every semester. There, the students learn how to run both a hydroponics system – which means there are no fish involved, but just chemicals in the water – and an aquaponics system, which uses fish.
'In the dome itself, there's two systems. There's one that is aquaponics with the fish living there,' he said. 'And there's one that's hydroponics as a drip system that kind of drips the nutrient rich water into the actual growing medium.'
As part of the curriculum, Paciotti covers plant science and botany. He said students learn about the anatomy and the physiology of plants, the growing techniques both in the soil and not in the soil. They also learn about the kind of nutrients plants need, but also how much light, space, oxygen and carbon dioxide they require.
'They go over things like the intensity of sunlight, what types of artificial lighting to use, growing seasons, hardiness, that kind of stuff, and then they apply that outside,' he said. 'On our workdays, they'll go outside, either work in the garden patches and start going in and planting this thing from seed, or they'll start inside with our aquaponics setup.'
Some of the things students grow are crops that are then used by the school cafeteria once the produce is ready to harvest. Paciotti said they supply about 25% of all the produce used in the cafeteria.
Since the class started, students' interest keeps growing, with a high enrollment. They have decided to move the class to a full course next year, with 45 students attending. Becoming a full course will allow Paciotti to add topics in the curriculum, like plant ecology, plant diversity, more traditional botany, but also sustainable agriculture.
Paciotti believes this class attracts more students because it is different from the traditional science classes that are offered.
'The other ones are focused more on the cell side of things, the human body. This one here kind of incorporates both environmental sciences, but also traditional botany and biology,' he said. 'And I think it's applicable more so after high school and some other disciplines, thinking about how this applies.'
Many students are currently living on a farm, and with the aquaponics class, they can learn a lot of things that they can apply directly into their homes. For those who do not live on a farm, they still learn how to grow their own crops, which can benefit them personally and professionally.
'Different plant companies are here growing plants and they need workers that go out there and work, so this provides skills that are more hands-on than the traditional class,' Paciotti said. 'And since they are outside for many classes in a row, it kind of gives them that real world experience while still being in high school.'
The feedback he received from students is positive. They like to be able to use their hands and work on the plants, something they usually have no experience with.
'It gets them outside in the dirt, in the water, working with both the fish and the plants and kind of giving them almost an escape from the traditional classroom setting,' he said.
Some of Paciotti's goals for the next few years would be to expand how much produce is going to the cafeteria, going from 25% to a third of what they use.
The original dome is deteriorating, so he is hoping to replace it by a full-size greenhouse with a similar type of set up. He is currently applying for a grant to get two indoor grow towers that use the nutrient film technique.
'It's kind of a hydroponic system that uses thin layers of water versus the entire tank down there,' he said. 'They are AI equipped, so the students can monitor from their phones and tablets how the plants are operating.'
This would allow students to see in real time the water and the nutrients level and watch the overall growth of the plant.
'Agriculture's been around for a couple thousand years, so it's kind of bringing the new technology into old technology,' he said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
35 minutes ago
- Forbes
U.S. Seniors Nearly Double Cannabis Use In Just Two Years, Study Finds
U.S. Seniors are turning to cannabis more than ever, with use nearly doubling in the past two years, a new study shows. Published this week in JAMA Internal Medicine, four researchers from the University of California and NYU Langone Health found that monthly cannabis use among adults aged 65 and older increased from 4.8% in 2021 to 7% in 2023, resulting in a 45.83% increase. The reasons for this increase are attributed to several factors, including greater access to cannabis. As of today, medical cannabis is legal in 39 states and Washington D.C., while 24 states have also legalized it for recreational use. The situation was slightly different in 2021, when medical cannabis was legal in 36 states and recreational use was legal in 17 states. In 2021, New York, Virginia, New Mexico, and Connecticut legalized cannabis for recreational use. The rise in access to cannabis, both medical and recreational, helps explain why more older adults are using it, especially as more people become aware of medical programs and the health issues cannabis can help treat. This cross-sectional study analyzed 15,689 adults aged 65 and older using data from the National Survey on Drug Use and Health (NSDUH), a nationwide survey of people in the U.S. who aren't living in institutions. The findings show that, between 2021 and 2023, cannabis use among older adults in the U.S. saw a significant rise, with some groups showing especially sharp increases. People with a college or postgraduate degree, for example, went from 4.9% to 8.3% in cannabis use. Among those earning $75,000 or more, cannabis use more than doubled, from 4.2% to 9.1%. Married adults also showed a big jump, going from 3.8% to 7.4%. Older adults living in states where medical cannabis is legal were more likely to use it, and that number kept climbing from 5.4% to 7.9%. 'It shouldn't be surprising that use is becoming increasingly more common among people who live in states that allow medical cannabis, which could be due to increased availability or social acceptability,' said Joseph Palamar, the study's senior author in a press statement, adding that 'with respect to income, those with the highest incomes had the lowest prevalence of cannabis use in 2021, but by 2023 this group had the highest prevalence, which may indicate who has access to medical cannabis given its costs.' The most dramatic increase came from people with chronic obstructive pulmonary disease (COPD), whose usage doubled from 6.4% to 13.5%. People with chronic conditions like cancer, diabetes, heart disease, and high blood pressure also reported using cannabis more. And those dealing with two or more chronic illnesses saw use rise from 3.5% to 8.2%. The authors of this study concluded that these findings show a real shift in how older adults are using cannabis, especially those living with chronic illnesses, and that people with multiple health conditions were more likely to use it. However, they also highlighted that 'the use of cannabis products, especially with psychoactive properties, may complicate chronic disease management among older adults.' These new findings line up with what earlier studies have shown. Back in 2020, a study published in the same journal looked at data from nearly 15,000 adults over 65 using the same national survey and found that cannabis use among older adults had already been on the rise for years, jumping from just 0.4% in 2006 and 2007 to 2.9% by 2015 and 2016. In recent years, researchers have also started to study how long-term cannabis use affects older adults. For example, a study published last year suggested that taking low doses of THC over time may not only help protect the brain from aging but also boost memory, improve cognitive function, and support seniors's overall well-being and longevity. This likely has to do with a key cellular pathway called mTOR, which is a protein that helps control how cells use energy and build new connections in the brain, which are important for learning and memory.


Forbes
39 minutes ago
- Forbes
Experts Warn Of Decade-Long Setback After Trump Cuts HIV Vaccine Research
NEW YORK - DECEMBER 1: Marina Kemelman, Research Associate at the AIDS Vaccine Design and ... More Development Laboratory, collects bacteria transfected with DNA as part of research at the laboratory's campus in the former Brooklyn Army Terminal December 1, 2008 in New York City. The laboratory, seeking a vaccine to prevent the spread of AIDS, is part of the International AIDS Vaccine Initiative (or IAVI), a global not-for-profit, public-private partnership working to accelerate the development of a vaccine to prevent HIV infection and AIDS. December 1 is the 20th annual World AIDS Day around the world. (Photo by) It was a rare moment of bipartisan unity. Standing before a joint session of Congress in January 2019, President Donald Trump boldly pledged to eradicate a disease that claims one life every single minute: HIV/AIDS. 'Scientific breakthroughs have brought a once-distant dream within reach,' Trump exclaimed. 'My budget will ask Democrats and Republicans to make the needed commitment to eliminate the HIV epidemic in the United States within 10 years. We have made incredible strides.' Then, he added, 'we will defeat AIDS in America and beyond.' That was then and this is now. Last week, a group of scientists working on promising HIV vaccine studies were reportedly informed that the administration plans to revoke their research grants in a move experts warn could set the movement back years. When the global AIDS crisis peaked in the early 2000s, roughly 5,000 people were dying every single day from the disease. Thanks to the leadership of governments, the private sector, and philanthropists, the world invested more resources into the AIDS fight than ever before. This spurred nearly two decades of progress—not just against AIDS, but across global health broadly. Since 2004, AIDS-related deaths have been reduced by roughly two-thirds. But recently, progress has slowed. Covid-19 proved a major health disruption that reversed years of hard-fought gains. Efforts to reduce mother-to-child transmission rates have slowed. Global health funding is now under siege not just in the United States, but across Europe, too. And the world is no longer on track to meet critical 2030 AIDS targets. The great paradox here is that never in human history has there been more tools available to fight AIDS. The cost of antiretroviral drugs has fallen from $27 a day in 2000 to as little as 10 cents a day. Now, experts say what's needed to get the fight back on track—and eventually end the threat for good—isn't just better diagnostics and therapeutics, but long acting preventatives. Fortunately, it's an area that's seen great progress. Dubbed the 'breakthrough of the year' in 2024 by the journal Science, Gilead Science's lenacapavir is a long-acting injectable vaccine that has proven incredibly effective at preventing HIV infections. It represents a major step forward from the prevalent pre-exposure prophylaxis (PrEP) pill and mitigates some of the major privacy, stigma, and adherence issues that come with taking daily medication. The next step forward could be a vaccine with even longer immunity—one that gives patients lifetime protection. Researchers have been pursuing this laudable goal for years, but last week, the Trump administration announced plans to terminate research grants at two preeminent institutions, the Duke Human Vaccine Institute and the Scripps Research Institute, totaling $258 million. The researchers were told that the administration wanted 'to go with currently available approaches to eliminate HIV.' On the other hand, global health experts are warning that without new resources, President Trump's promise to end HIV within ten years is destined to fail—and when combined with the administration's other actions to cut and halt global health programs, HIV infections and deaths could actually rise for the first time in decades under his watch. 'I find it very disappointing that, at this critical juncture, the funding for highly successful H.I.V. vaccine research programs should be pulled,' Dennis Burton, an immunologist at Scripps, told The New York Times. Meanwhile AIDS groups, including the AIDS Vaccine Advocacy Coalition described the decision as inconceivable and shortsighted. The grant news marks the latest blow to the HIV/AIDS community, which has endured devastating domestic and global funding cuts in Trump's second term. San Francisco, which was one of the first epicenters of the domestic AIDS fight, has long relied on funding from the federal government to support community-based health programs that help reduce HIV transmission. These initiatives have helped the city make outstanding progress against the disease, but Centers for Disease Control and Prevention (CDC) grant delays have threatened testing, treatment, and care continuity. Even southern states which President Trump won decisively, and which account for 50% of all new U.S. HIV infections, have not been spared. According to the Foundation for AIDS Research (amfAR), cuts to domestic HIV prevention programs could spark over 14,000 additional deaths from AIDS-related causes and 143,000 new HIV infections. Earlier this year, HHS closed its Office of Infectious Diseases & HIV policy that quarterbacked the government's domestic AIDS response. Abroad, global health programs have fared even worse. In January, the Trump administration halted funding for The President's Emergency Plan for AIDS Relief (PEPFAR), a bipartisan program that has saved over 26 million lives. In a congressional hearing last week, Secretary of State Marco Rubio said that, '85 percent of recipients are now receiving PEPFAR services.' He also said that no one has died as a result of the aid freeze, a notion journalists and health experts scoff at. According to Brooke Nichols, an infectious disease mathematical modeler and health economist at Boston University, over 57,000 adults and 6,000 children have died as a result of the PEPFAR funding freeze and the discontinuation of global health programs. Even if those numbers are inflated, as some have contended, the number of lives needlessly lost is still likely in the tens of thousands. While some experts remain hopeful that the recent cuts will eventually be restored, the prospect of an AIDS-free future that President Trump himself once espoused appears grim. "This is a decision with consequences that will linger. This is a setback of probably a decade for HIV vaccine research," Burton warned.


TechCrunch
40 minutes ago
- TechCrunch
Google says its updated Gemini 2.5 Pro AI model is better at coding
In Brief Google on Thursday announced an update to its Gemini 2.5 Pro preview model that the company claims is better at certain programming tasks. The company's calling it an 'updated preview,' building on the upgrade to Gemini 2.5 Pro that Google announced around a month ago. Google says the model will roll out in general availability in a 'couple of weeks,' and is available starting today in its AI developer platforms AI Studio and Vertex AI and the Gemini app. Image Credits:Google '[Gemini 2.5 Pro] continues to excel at coding, leading on difficult coding benchmarks,' Google writes in a blog post. 'It also shows top-tier performance [on] highly challenging benchmarks that evaluate a model's math, science, knowledge, and reasoning capabilities.' So what else is new? Google says it addressed feedback from its previous 2.5 Pro release, improving the model's style and structure. Now, 2.5 Pro can be 'more creative with better-formatted responses,' Google claims.